NYSE · Health Care

BRITISH AMERN TOB PLC BTI

British American Tobacco is a global tobacco group that is driving sustainable growth through business transformation and is committed to building a "better tomorrow". Investors can pay attention to its pre-disclosure for the first half of 2026 and preliminary results for 2025.

Medicinal Chemicals and Botanical Products

Company profile

Business mix

  • Business Focus: The company emphasizes business transformation to achieve sustainable growth and "Better Tomorrow" goals.
  • Latest news: The trading update for the first half of 2026 has been released, and the CEO and other management will hold an investor conference call.
  • Investor resources: Provide key disclosure documents such as 2025 full-year results, annual report and sustainability report.

Current key questions

  • Under regulatory pressure and rising health awareness, companies need to accelerate their transformation to low-risk product portfolios.
  • The traditional tobacco business faces the risk of long-term decline, and whether new categories can continue to grow is the key.
  • Shareholder services: The website provides practical functions such as dividend calculation, shareholder meeting information and financial calendar.
Holders 3 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE 12.33 FCF 6.06% Buyback 1.17%
2026-06-07

Current firm holders

Firm Weight Value Filing period
GQG Partners Rajiv Jain 2.6% $1.6B 2026-03-31
First Eagle legacy Jean-Marie Eveillard 0.1% $97.6M 2026-03-31
Bridgewater Associates Ray Dalio 0.2% $44.8M 2026-03-31

Recent trading changes over the last 2 quarters

Net buyers 1 Last 2 13F filing periods
Net reducers 2 Last 2 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $22.5M Estimated from net added shares
Reduction amount $225.0M Estimated from net reduced shares
Net share change / base shares -10.3% -3,464,435 / 33,582,139
Bridgewater Associates Ray Dalio 2 filing periods
13F 2025-12-31 Filed 2026-02-13
Major reduction Shares -21.1% 13F value change -$31.5M
13F 2026-03-31 Filed 2026-05-15
Major reduction Shares -74.1% 13F value change -$122.4M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 3,742,720 Last 2 periods -2,976,872 (-79.5%) Total shares 765,848 Value $44.8M
GQG Partners Rajiv Jain 2 filing periods
13F 2025-12-31 Filed 2026-02-13
Minor reduction Shares -1.7% 13F value change +$73.2M
13F 2026-03-31 Filed 2026-05-12
Minor reduction Shares -1.4% 13F value change +$29.7M
Settlement As of 13F 2026-03-31 · Filed 2026-05-12
Base shares 28,554,869 Last 2 periods -871,535 (-3.1%) Total shares 27,683,334 Value $1.6B
First Eagle legacy Jean-Marie Eveillard 2 filing periods
13F 2025-12-31 Filed 2026-02-04
Minor increase Shares 9.6% 13F value change +$11.5M
13F 2026-03-31 Filed 2026-05-12
Major increase Shares 18.5% 13F value change +$17.8M
Settlement As of 13F 2026-03-31 · Filed 2026-05-12
Base shares 1,284,550 Last 2 periods +383,972 (+29.9%) Total shares 1,668,522 Value $97.6M

Recent mentions

No public mentions.